MIRA INFORM REPORT

 

 

Report Date :

28.01.2013

 

IDENTIFICATION DETAILS

 

Name :

BIOZEN  CO.,  LTD.

 

 

Registered Office :

23  Soi  Onnuch  62,  Onnuch  Road,  Suanluang,  Bangkok  10250 

 

 

Country :

Thailand

 

 

Financials (as on) :

31.12.2011

 

 

Date of Incorporation :

20.03.1995

 

 

Com. Reg. No.:

0105538035475

 

 

Legal Form :

Private  Limited  Company

 

 

Line of Business :

Importer and  Distributor of Medical  Equipment  and  Lab  Instrument

 

 

No. of Employees :

70

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

Payment Behaviour :

No Complaints

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 30th, 2012

 

Country Name

Previous Rating

(31.03.2011)

Current Rating

(30.06.2012)

Thailand

B1

B1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

THAILAND - ECONOMIC OVERVIEW

 

With a well-developed infrastructure, a free-enterprise economy, generally pro-investment policies, and strong export industries, Thailand enjoyed solid growth from 2000 to 2007 - averaging more than 4% per year - as it recovered from the Asian financial crisis of 1997-98. Thai exports - mostly machinery and electronic components, agricultural commodities, and jewelry - continue to drive the economy, accounting for more than half of GDP. The global financial crisis of 2008-09 severely cut Thailand's exports, with most sectors experiencing double-digit drops. In 2009, the economy contracted 2.3%. In 2010, Thailand's economy expanded 7.8%, its fastest pace since 1995, as exports rebounded from their depressed 2009 level. Steady economic growth at just below 4% during the first three quarters of 2011 was interrupted by historic flooding in October and November in the industrial areas north of Bangkok, crippling the manufacturing sector and leading to a revised growth rate of only 0.1% for the year. The industrial sector is poised to recover from the second quarter of 2012 onward, however, and the government anticipates the economy will probably grow between 5.5 and 6.5% for 2012, while private sector forecasts range between 3.8% and 5.7%.

Source : CIA


Company name 

 

BIOZEN  CO.,  LTD.

 

 

SUMMARY

 

BUSINESS  ADDRESS                          :           23  SOI  ONNUCH  62,  ONNUCH  ROAD, 

                                                                        SUANLUANG,  BANGKOK  10250,  THAILAND

TELEPHONE                                         :           [66]   2704-6407

FAX                                                      :           [66]   2704-6229

E-MAIL  ADDRESS                                :           admin@biozen.co.th

                                                                        biozen02@hotmail.com

REGISTRATION  ADDRESS                  :           SAME  AS  BUSINESS  ADDRESS

 

ESTABLISHED                                     :           1995

REGISTRATION  NO.                           :           0105538035475

TAX  ID  NO.                                         :           3011554500

CAPITAL REGISTERED                         :           BHT.   18,000,000

CAPITAL PAID-UP                                :           BHT.   18,000,000

SHAREHOLDER’S  PROPORTION         :           THAI        :    100%

FISCAL YEAR CLOSING DATE              :           DECEMBER   31            

LEGAL  STATUS                                  :           PRIVATE  LIMITED  COMPANY

EXECUTIVE                                          :           MR. JIRADECH  THEPCHUAY,  THAI

                                                                        MANAGING  DIRECTOR           

 

NO.  OF  STAFF                                   :           70

LINES  OF  BUSINESS                          :           MEDICAL  EQUIPMENT  AND  LAB  INSTRUMENT

                                                                        IMPORTER  AND  DISTRIBUTOR

                                   

                                     

CORPORATE  PROFILE

 

OPERATING  TREND                            :           STABLE                       

PRESENT  SITUATION                          :           OPERATING  NORMALLY                     

REPUTATION                                       :           GOOD  WITH  NORMAL  BUSINESS  ENGAGEMENT

MANAGEMENT  STANDARD                 :           MANAGEMENT  WITH  GOOD  PERFORMANCE                       

 

 

 

 


HISTORY

 

The  subject  was  established  on  March  20,  1995  as  a  private  limited  company  under  the  registered  name  BIOZEN   CO.,  LTD.  by  Thai groups,  with  the business  objective  to  import  and  distribute  various  kinds  of  medical  equipment  and  lab  instruments  to  domestic  market.   It  currently  employs  approximately 70  staff.  

 

The  subject’s  registered  address  is  23  Soi  Onnuch  62, Onnuch Rd.,  Suanluang,  Bangkok  10250,  and  this  is  the  subject’s  current  operation  address.  

 

 

THE  BOARD  OF  DIRECTOR

 

Mr. Jiradech  Thepchuay

 

 

AUTHORIZED  PERSON

 

The  above  director  signs  on  behalf  of  the  subject  with  company’s  affixed.

 

 

MANAGEMENT

 

Mr. Jiradech  Thepchuay   is  the  Managing  Director.

He  is  Thai  nationality  with  the  age  of  46  years  old.  

 

 

BUSINESS  OPERATIONS

 

The  subject  is  engaged  in  importing  and  distributing  various  kinds  of  medical  equipment,  such  as  automated  chemistry  analyzer,  semi-automated  chemistry  analyzer,  electrolyte  analyzer,  urine  strip  reader,  ESR  system  analyzer,  as  well  as  lab  instruments.

 

MAJOR  BRAND

 

“APEL”,  “BIOTECNICA”,  “VACUTEST  KIMA”,  “ERBA  MANNHEIM”

 

PURCHASE

 

90%  of  the  products  is  imported  from  Japan,  France,  Italy,  Republic  of  China,  India,  and  Germany,  the  remaining  10%  is  purchased  from  local  suppliers.

 

MAJOR  SUPPLIERS

 

Apel  Co.,  Ltd.                                      :  Japan

Biotecnica  S.p.a.                                              :  Italy

Vacutest  Kima  S.r.l.                                         :  Italy

Erba  Diagnostics  Mannheim  GmbH.                 :  Germany

 

 

SALES 

 

100%  of  the  products  is  sold  locally  by  wholesale  to  end-users  mainly   hospital  and  medical  center  nationwide  both  private  and  government  sectors.

 

 

SUBSIDIARY  AND  AFFILIATED  COMPANY

 

The  subject  is  not  found  to  have  any  subsidiary  or  affiliated  company  here  in  Thailand.

 

 

LITIGATION

 

Bankruptcy  and  Receivership

 

There  are  no  litigation  on  bankruptcy  and  receivership  cases  filed  against  the  subject  found  at  Legal  Execution  Department  for  the  past  five  years.

 

Others

 

There  are  no  legal  suits  filed  against   the  subject  for  the  past  two  years.

 

CREDIT  

 

Sales  are  by  cash  or  on  the  credits  term  of  30-60  days.

Local  bills  are  paid  by  cash  or  on  the  credits  term  of  30-60  days.

Imports  are  by  D/A  and  T/T.

 

 

BANKING

 

The  Siam  Commercial  Bank  Public  Co.,  Ltd.

 

 

EMPLOYMENT

 

The  subject  currently  employs  approximately  70  staff.  

 

LOCATION  DETAILS

 

The  premise  is rented for  administrative  office  at  the  heading  address.  Premise  is  located  in  commercial/residential  area.

 

Warehouse  is  located  at  330  Soi  Onnuch  40,  Onnuch  Rd.,  Suanluang,  Bangkok  10250.

 

 

COMMENT

 

The  subject’s  operating  performance  in  2011  was  satisfactory  with  an  increase in  both  sales  revenue  and  net  profit  comparing  to  the  previous  year’s  level.  There  is  a   high  demand  of  medical  equipment  and supplies  from  both  private  and  public  hospitals  on  a  yearly  basis  in  relation  to the  growth  of  healthcare  industry.  Its  business is  promising  and growing  considerably.

 

 

FINANCIAL  INFORMATION

 

The  capital  was  registered  at  Bht.  3,000,000  divided  into 30,000  shares  of  Bht.  100     each  with  fully  paid.

 

The  capital  was  increased  later  as  follows:

 

            Bht.    4,000,000  on      July  3,  1996

            Bht.  18,000,000  on       December  11,  2002

 

The  latest  registered  capital  was  increased  to  Bht.  18,000,000  divided  into  180,000  shares  of  Bht. 100  each  with  fully  paid.

 

THE  SHAREHOLDERS  LISTED  WERE  :  [as  at  June  6,  2012]

 

       NAME

HOLDING

%

 

 

 

Mr. Jiradech  Thepchuay

Nationality:  Thai

Address     :  23  Soi  Onnuch  62,  Onnuch  Rd., 

                     Suanluang,  Bangkok

100,000

55.56

Ms. Jarunee  Thepchuay

Nationality:  Thai

Address     :  555/140  Moo  1,  Theparak  Rd., 

                     Praeksamai,  Muang,  Samutprakarn

40,000

22.22

Mr. Jaruek  Thepchuay

Nationality:  Thai

Address     :  274  Moo  6,  Samrongnua,  Muang,

                     Samutprakarn

40,000

22.22

 

Total  Shareholders  :  3

 

Share  Structure  [as  at  June  6,  2012]

 

Nationality

Shareholders

No. of  Share

% Shares

 

 

 

 

Thai

3

180,000

100.00

Foreign

-

-

-

 

Total

 

3

 

180,000

 

100.00

 

NAME  OF  AUDITOR  &  CERTIFIED  PUBLIC  ACCOUNTANT  NO. :

 

Mr. Rangsarit  Duangnate  No.  1418

 

 

BALANCE SHEET [BAHT]

 

The  latest  financial figures  published  as  at  December  31,  2011,  2010  &  2009  were:

          

ASSETS

                                                                                                 

Current Assets

2011

2010

2009

 

 

 

 

Cash  and Cash Equivalents     

3,175,361.97

5,956,491.41

3,177,690.15

Trade  Accounts  &  Other  Receivable 

136,770,751.69

118,661,850.09

93,786,607.35

Inventories     

13,989,829.77

15,092,064.68

13,715,892.48

Other  Current  Assets                  

246,511.21

-

9,083,370.37

 

 

 

 

Total  Current  Assets                

154,182,454.64

139,710,406.18

119,763,560.35

 

 

 

 

Fixed Assets

47,523,722.14

45,524,889.84

45,275,734.78

Other  Non-current  Assets                      

232,407.24

694,291.22

3,178,630.59

 

Total  Assets                 

 

201,938,584.02

 

185,929,587.24

 

168,217,925.72

 

 

LIABILITIES & SHAREHOLDERS’ EQUITY [BAHT]

 

 

Current Liabilities

2011

2010

2009

 

 

 

 

Trade  Accounts  & Other  Payable    

6,729,442.29

10,456,203.19

5,001,142.49

Accrued Income Tax

686,242.44

467,557.48

-

Other  Current  Liabilities             

1,319,498.39

1,582,417.38

5,709,109.48

 

 

 

 

Total Current Liabilities

8,735,183.12

12,506,178.05

10,710,251.97

 

Long-term Loan 

 

142,212,894.66

 

128,812,894.66

 

117,359,161.50

Long-term Loan  from  Person  or

  Related  Company

 

-

 

-

 

23,211.99

Other Non-current Liabilities

-

-

185,694.85

 

Total  Liabilities            

 

150,948,077.78

 

141,319,072.71

 

128,278,320.31

 

 

 

 

Shareholders' Equity

 

 

 

 

 

 

 

Share  capital : Baht  100  par  value 

  authorized,  issued  and  fully 

  paid  share  capital  180,000  shares

 

 

18,000,000.00

 

 

18,000,000.00

 

 

18,000,000.00

 

 

 

 

Capital  Paid                      

18,000,000.00

18,000,000.00

18,000,000.00

Retained Earning  Unappropriated

32,990,506.24

26,610,514.53

21,939,605.41

 

Total Shareholders' Equity

 

50,990,506.24

 

44,610,514.53

 

39,939,605.41

 

Total Liabilities  &  Shareholders' 

   Equity

 

 

201,938,584.02

 

 

185,929,587.24

 

 

168,217,925.72

 

                                                  

PROFIT & LOSS ACCOUNT

 

 Revenue

2011

2010

2009

 

 

 

 

Sales  Income

168,561,621.30

155,599,988.14

133,256,976.46

Other  Income                 

113,300.12

6,420,051.73

5,104,894.67

 

Total  Revenues           

 

168,674,921.42

 

162,020,039.87

 

138,361,871.13

 

Expenses

 

 

 

 

 

 

 

Cost  of  Goods  Sold 

68,521,264.60

62,556,062.83

62,978,453.57

Selling  Expenses

42,306,651.42

44,105,901.21

28,486,810.71

Administrative  Expenses

47,994,652.35

47,120,875.02

41,295,481.11

Other Expenses

637,262.55

1,236,446.08

742,307.63

 

Total Expenses             

 

159,459,830.92

 

155,019,285.14

 

133,503,053.02

 

 

 

 

Profit / [Loss]  before  Financial  Cost

  &  Income  Tax

 

9,215,090.50

 

7,000,754.73

 

4,858,818.11

Financial  Costs

-

-

[691.40]

 

Profit / [Loss]  before  Income  Tax

 

9,215,090.50

 

7,000,754.73

 

4,858,126.71

Income  Tax

[2,835,098.79]

[2,329,845.61]

[1,831,599.93]

 

 

 

 

Net  Profit / [Loss]

6,379,991.71

4,670,909.12

3,026,526.78

 

 

 


 

FINANCIAL ANALYSIS

 

ITEM

UNIT

2011

2010

2009

 

 

 

 

 

LIQUIDITY RATIO

 

 

 

 

CURRENT RATIO

TIMES

17.65

11.17

11.18

QUICK RATIO

TIMES

16.02

9.96

9.05

 

 

 

 

 

ACTIVITY RATIO

 

 

 

 

FIXED ASSETS TURNOVER

TIMES

3.55

3.42

2.94

TOTAL ASSETS TURNOVER

TIMES

0.83

0.84

0.79

INVENTORY CONVERSION PERIOD

DAYS

74.52

88.06

79.49

INVENTORY TURNOVER

TIMES

4.90

4.14

4.59

RECEIVABLES CONVERSION PERIOD

DAYS

296.16

278.35

256.89

RECEIVABLES TURNOVER

TIMES

1.23

1.31

1.42

PAYABLES CONVERSION PERIOD

DAYS

35.85

61.01

28.98

CASH CONVERSION CYCLE

DAYS

334.84

305.40

307.40

 

 

 

 

 

PROFITABILITY RATIO

 

 

 

 

COST OF GOODS SOLD

%

40.65

40.20

47.26

SELLING & ADMINISTRATION

%

53.57

58.63

52.37

INTEREST

%

-

-

0.00

GROSS PROFIT MARGIN

%

59.42

63.92

56.57

NET PROFIT MARGIN BEFORE EX. ITEM

%

5.47

4.50

3.65

NET PROFIT MARGIN

%

3.78

3.00

2.27

RETURN ON EQUITY

%

12.51

10.47

7.58

RETURN ON ASSET

%

3.16

2.51

1.80

EARNING PER SHARE

BAHT

35.44

25.95

16.81

 

 

 

 

 

LEVERAGE RATIO

 

 

 

  

DEBT RATIO

TIMES

0.75

0.76

0.76

DEBT TO EQUITY RATIO

TIMES

2.96

3.17

3.21

TIME INTEREST EARNED

TIMES

-

-

7,027.51

 

 

 

 

 

ANNUAL GROWTH

 

 

 

 

SALES GROWTH

%

8.33

16.77

 

OPERATING PROFIT

%

31.63

44.08

 

NET PROFIT

%

36.59

54.33

 

FIXED ASSETS

%

4.39

0.55

 

TOTAL ASSETS

%

8.61

10.53

 

 

 


ANNUAL GROWTH : EXCELLENT

 

An annual sales growth is 8.33%. Turnover has increased from THB 155,599,988.14 in 2010 to THB 168,561,621.30 in 2011. While net profit has increased from THB 4,670,909.12 in 2010 to THB 6,379,991.71 in 2011. And total assets has increased from THB 185,929,587.24 in 2010 to THB 201,938,584.02 in 2011.                   

           

           

PROFITABILITY : IMPRESSIVE

 

 

PROFITABILITY RATIO

 

Gross Profit Margin

59.42

Impressive

Industrial Average

27.99

Net Profit Margin

3.78

Impressive

Industrial Average

2.26

Return on Assets

3.16

Satisfactory

Industrial Average

3.26

Return on Equity

12.51

Impressive

Industrial Average

8.23

 

Gross Profit Margin used to assess a firm's financial health by revealing the proportion of money left over from revenues after accounting for the cost of goods sold. Gross profit margin serves as the source for paying additional expenses and future savings. Gross Profit Margin is  59.42%. When compared with the industry average, the ratio of the company was higher, indicated that company was more profitable than the same industry.

 

Net Profit Margin is the indicator of the company's efficiency in that net profit takes into consideration all expenses of the company. A low profit margin indicates a low margin of safety, higher risk that a decline in sales will erase profits and result in a net loss. Net Profit Margin ratio is 3.78%, higher  figure when compared with those of its average competitors in the same industry, indicated that business was an efficient operator in a dominant position within its industry.


 

Return on Assets measures how efficiently profits are being generated from the assets employed in the business when compared with the ratios of firms in a similar business. A low ratio in comparison with industry averages indicates an inefficient use of business assets. When compared with the industry average, it was lower, the company's figure is 3.16%.

 

Return on Equity indicates how profitable a company is by comparing its net income to its average shareholders' equity, ROE measures how much the shareholders earned for their investment in the company. Return on Equity ratio is 12.51%, higher figure when compared with those of its average competitors in the same industry, indicated that business was an efficient profit in a dominant position within its industry.

 

Trend of the average competitors in the same industry for last 5 years

Return on Assets                       Downtrend

Return on Equity                        Downtrend

 

 

LIQUIDITY : SATISFACTORY

 

 

 

LIQUIDITY RATIO

 

Current Ratio

17.65

Impressive

Industrial Average

1.54

Quick Ratio

16.02

 

 

 

Cash Conversion Cycle

334.84

 

 

 

 

The Current Ratio is to ascertain whether a company's short-term assets are readily available to pay off its short-term liabilities. The company's figure is 17.65 times in 2011, increase from 11.17 times, then it is generally considered to have good short-term financial strength. When compared with the industry average, the ratio of the company was higher, indicated that company was an efficient operator in a dominant position within its industry.

 

The Quick Ratio is a liquidity indicator that further refines the current ratio by measuring the amount of the most liquid current assets there are to cover current liabilities. The company's figure is 16.02 times in 2011, increase from 9.96 times, although excluding inventory so the company still have good short-term financial strength.

 

The Cash Conversion Cycle measures the number of days a company's cash is tied up in the production and sales process of its operations and the benefit from payment terms from its creditors. It meant the company could survive when no cash inflow was received from sale for 335 days.

 

Trend of the average competitors in the same industry for last 5 years

Current Ratio                 Downtrend

 

LEVERAGE : RISKY

 

 

 

 

LEVERAGE RATIO

 

Debt Ratio

0.75

Acceptable

Industrial Average

0.60

Debt to Equity Ratio

2.96

Risky

Industrial Average

1.54

Times Interest Earned

-

 

Industrial Average

2.05

 

Debt to Equity Ratio a measurement of how much suppliers, lenders, creditors and obligors have committed to the company versus what the shareholders have committed. A lower the percentage means that the company is using less leverage and has a stronger equity position.

 

Debt Ratio shows the proportion of a company's assets which are financed through debt. The company's figure is 0.75 greater than 0.5, most of the company's assets are financed through debt.

 

Trend of the average competitors in the same industry for last 5 years

Debt Ratio                                 Downtrend

Times Interest Earned                Uptrend

 

ACTIVITY : SATISFACTORY

 

 

 

 

ACTIVITY RATIO

 

Fixed Assets Turnover

3.55

Acceptable

Industrial Average

5.50

Total Assets Turnover

0.83

Acceptable

Industrial Average

1.44

Inventory Conversion Period

74.52

 

 

 

Inventory Turnover

4.90

Impressive

Industrial Average

3.97

Receivables Conversion Period

296.16

 

 

 

Receivables Turnover

1.23

Acceptable

Industrial Average

2.31

Payables Conversion Period

35.85

 

 

 

 

The company's Account Receivable Ratio is calculated as 1.23 and 1.31 in 2011 and 2010 respectively. This ratio measures the efficiency of the company in managing its trade debtors to generate revenue. A lower ratio may indicate over extension and collection problems. Conversely, a higher ratio may indicate an overtly stringent policy. In this case, the company's A/R ratio in 2011 decreased from 2010. This would suggest the company had deteriorated in the management of its debt collections.

 

Inventory Turnover in Days Ratio indicates the liquidity of inventory. It estimates the number of days that it will take to sell the current inventory. Inventory is particularly sensitive to change in business activities. The inventory turnover in days has decreased from 88 days at the end of 2010 to 75 days at the end of 2011. This represents a positive trend. And Inventory turnover has increased from 4.14 times in year 2010 to 4.9 times in year 2011.

 

The company's Total Asset Turnover is calculated as 0.83 times and 0.84 times in 2011 and 2010 respectively. This ratio is determined by dividing total assets into total sales turnover. The ratio measures the activity of the assets and the ability of the firm to generate sales through the use of the assets.

 

Trend of the average competitors in the same industry for last 5 years

Fixed Assets Turnover                Downtrend

Total Assets Turnover                 Downtrend

Inventory Turnover                      Uptrend

Receivables Turnover                  Downtrend

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.53.85

UK Pound

1

Rs.85.25

Euro

1

Rs.71.72

 

 

INFORMATION DETAILS

 

Report Prepared by :

PRL

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.